QIAGEN GmbH
QIAGEN – listed on the NYSE and a member of the DAX-40 - is the leading global provider of Sample to Insight solutions that enable customers to gain valuable molecular insights from samples containing the building blocks of life – DNA, RNA and proteins.
Our more than 6,000 QIAGENers provide solutions to more than 500,000 customers around the world in Molecular Diagnostics (human healthcare) and Life Sciences (academia, pharma R&D and industrial applications, primarily forensics).